Morgan, M.A.; Kloos, A.; Lenz, D.; Kattre, N.; Nowak, J.; Bentele, M.; Keisker, M.; Dahlke, J.; Zimmermann, K.; Sauer, M.;
et al. Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123. Viruses 2021, 13, 1365.
https://doi.org/10.3390/v13071365
AMA Style
Morgan MA, Kloos A, Lenz D, Kattre N, Nowak J, Bentele M, Keisker M, Dahlke J, Zimmermann K, Sauer M,
et al. Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123. Viruses. 2021; 13(7):1365.
https://doi.org/10.3390/v13071365
Chicago/Turabian Style
Morgan, Michael A., Arnold Kloos, Daniela Lenz, Nadine Kattre, Juliette Nowak, Marco Bentele, Maximilian Keisker, Julia Dahlke, Katharina Zimmermann, Martin Sauer,
and et al. 2021. "Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123" Viruses 13, no. 7: 1365.
https://doi.org/10.3390/v13071365
APA Style
Morgan, M. A., Kloos, A., Lenz, D., Kattre, N., Nowak, J., Bentele, M., Keisker, M., Dahlke, J., Zimmermann, K., Sauer, M., Heuser, M., & Schambach, A.
(2021). Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123. Viruses, 13(7), 1365.
https://doi.org/10.3390/v13071365